RC-3095, a Selective Gastrin-Releasing Peptide Receptor Antagonist, Does Not Protect the Lungs in an Experimental Model of Lung Ischemia-Reperfusion Injury

<div>Photomicrograph of the lung in the different experimental groups. The histological score (HIS) showed no significant difference between groups (<i>P</i> = 0.973) (A: SHAM, B: IR, C: RC-Pre, and D: RC-Post, magnification ×100).</div>

BioMed Research International

fig2

Figure 2

Figure 2: RC-3095, a Selective Gastrin-Releasing Peptide Receptor Antagonist, Does Not Protect the Lungs in an Experimental Model of Lung Ischemia-Reperfusion Injury 

Figure 2 | RC-3095, a Selective Gastrin-Releasing Peptide Receptor Antagonist, Does Not Protect the Lungs in an Experimental Model of Lung Ischemia-Reperfusion Injury 